Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Geoerger

Showing results (61-70 of 179) with videos related to

Pageof 18
Sort By:
Neuro-Oncology|December 24, 2014
Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine gliomaNathalène Truffaux, Cathy Philippe, Janna Paulsson, et al.
Targeted Oncology|March 16, 2026
Phase I/II Study of the CDK2/9 Inhibitor Fadraciclib in Combination with Chemotherapy in Children with Advanced Malignancies: Arm K of the AcSé-ESMART TrialAlba Rubio-San-Simón, Lynley V Marshall, Eleni Karamouza, et al.
Pediatric Blood & Cancer|November 1, 2018
Integrated analysis of long-term growth and bone development in pediatric and adolescent patients receiving bevacizumabHermann L Müller, Johannes H M Merks, Birgit Geoerger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Preliminary efficacy of the anti-insulin-like growth factor type 1 receptor antibody figitumumab in patients with refractory Ewing sarcomaHeribert Juergens, Najat C Daw, Birgit Geoerger, et al.
Oncotarget|October 8, 2016
A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumorsAndrew D J Pearson, Sara M Federico, Isabelle Aerts, et al.
European Journal of Cancer (Oxford, England : 1990)|September 25, 2008
A phase II study of irinotecan in children with relapsed or refractory neuroblastoma: a European cooperation of the Société Française d'Oncologie Pédiatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG)Gilles Vassal, Francesco Giammarile, Mariel Brooks, et al.
European Journal of Cancer (Oxford, England : 1990)|May 18, 2016
Phase 1 study of dalotuzumab monotherapy and ridaforolimus-dalotuzumab combination therapy in paediatric patients with advanced solid tumoursDidier Frappaz, Sara M Federico, Andrew D J Pearson, et al.
Blood|December 15, 2010
Monocytic cells derived from human embryonic stem cells and fetal liver share common differentiation pathways and homeostatic functionsOlena Klimchenko, Antonio Di Stefano, Birgit Geoerger, et al.
Cancer Research|August 30, 2012
Targeting the EWSR1-FLI1 oncogene-induced protein kinase PKC-β abolishes ewing sarcoma growthDidier Surdez, Magdalena Benetkiewicz, Virginie Perrin, et al.
Proteomics|July 20, 2017
Proteomic Analysis of Neuroblastoma-Derived Exosomes: New Insights into a Metastatic SignatureMarta Colletti, Andrea Petretto, Angela Galardi, et al.
Pageof 18

Showing results (61-70 of 179) with videos related to

Sort By:
Pageof 18
Neuro-Oncology|December 24, 2014
Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine gliomaNathalène Truffaux, Cathy Philippe, Janna Paulsson, et al.
Targeted Oncology|March 16, 2026
Phase I/II Study of the CDK2/9 Inhibitor Fadraciclib in Combination with Chemotherapy in Children with Advanced Malignancies: Arm K of the AcSé-ESMART TrialAlba Rubio-San-Simón, Lynley V Marshall, Eleni Karamouza, et al.
Pediatric Blood & Cancer|November 1, 2018
Integrated analysis of long-term growth and bone development in pediatric and adolescent patients receiving bevacizumabHermann L Müller, Johannes H M Merks, Birgit Geoerger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Preliminary efficacy of the anti-insulin-like growth factor type 1 receptor antibody figitumumab in patients with refractory Ewing sarcomaHeribert Juergens, Najat C Daw, Birgit Geoerger, et al.
Oncotarget|October 8, 2016
A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumorsAndrew D J Pearson, Sara M Federico, Isabelle Aerts, et al.
European Journal of Cancer (Oxford, England : 1990)|September 25, 2008
A phase II study of irinotecan in children with relapsed or refractory neuroblastoma: a European cooperation of the Société Française d'Oncologie Pédiatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG)Gilles Vassal, Francesco Giammarile, Mariel Brooks, et al.
European Journal of Cancer (Oxford, England : 1990)|May 18, 2016
Phase 1 study of dalotuzumab monotherapy and ridaforolimus-dalotuzumab combination therapy in paediatric patients with advanced solid tumoursDidier Frappaz, Sara M Federico, Andrew D J Pearson, et al.
Blood|December 15, 2010
Monocytic cells derived from human embryonic stem cells and fetal liver share common differentiation pathways and homeostatic functionsOlena Klimchenko, Antonio Di Stefano, Birgit Geoerger, et al.
Cancer Research|August 30, 2012
Targeting the EWSR1-FLI1 oncogene-induced protein kinase PKC-β abolishes ewing sarcoma growthDidier Surdez, Magdalena Benetkiewicz, Virginie Perrin, et al.
Proteomics|July 20, 2017
Proteomic Analysis of Neuroblastoma-Derived Exosomes: New Insights into a Metastatic SignatureMarta Colletti, Andrea Petretto, Angela Galardi, et al.
Pageof 18